| | 
Part, Chapter, Paragraph
1 II, 5. 3. 2| from 34 European countries regarding teaching and continuing
2 II, 5. 3. 2| survey/~ ~A global comparison regarding patient access to cancer
3 II, 5. 3. 7| entitled “A global comparison regarding patient access to cancer
4 II, 5. 3. 7| highlights the inequities regarding the ability of patients
5 II, 5. 3. 7| Technology Assessment (HTA) regarding a new cancer drug is done
6 II, 5. 3. 8| information on best practices regarding diagnosis, treatment, rehabilitation
7 II, 5. 5.Int| patients’ needs in areas regarding the development of policies
8 II, 5. 5. 2| huge information deficit regarding Alzheimer’s disease;~· As
9 II, 5. 5. 3| are partly very different regarding the sampling design and
10 II, 5. 5. 3| to regularly update data regarding eating disorders. Routinely
11 II, 5. 5. 3| decisions and strategies regarding mental health policy.~Mortality~
12 II, 5. 5. 3| from Sweden were available. Regarding the prescription of atypical
13 II, 5. 5. 3| Europe. In contrast, data regarding the mortality in patients
14 II, 5. 5. 3| and practice parameters regarding the management of epilepsy
15 II, 5. 5. 3| legislations of the EU governments regarding employment and driving in
16 II, 5. 5. 3| those diagnosed with MS regarding the Directive, its scope
17 II, 5. 5. 3| health technology assessments regarding the management of PD have
18 II, 5. 7. 5| CKD diagnosis. Policies regarding evaluation of care including
19 II, 5. 7. 6| national health policies regarding RRT for ESRD. In contrast,
20 II, 5. 8. 3| there are some problems regarding the accuracy of COPD mortality
21 II, 5. 9. FB| the two groups were found regarding the incidence of atopy and
22 II, 5. 9. 6| among existing programs regarding chronic respiratory diseases.
23 II, 5. 10. 4| of health professionals regarding the disease. On the other
24 II, 5. 10. 5| allergy and food intolerance regarding the labelling of substances
25 II, 5. 11. 3| industry, in particular those regarding toxicity requirements and
26 II, 5. 11. 3| receive good medical advice regarding the most appropriate treatment
27 II, 5. 11. 3| collected and available regarding NMSC in Europe. In Trentino,
28 II, 5. 14. 3| limitation has implications regarding the use of oral disadvantage
29 II, 5. 15. 3| published report available regarding the contribution of RD to
30 II, 5. 15. 4| been recently published regarding the experience acquired
31 II, 7. 4 | human suffering;~· Evidence regarding the effectiveness of interventions
32 II, 7. 4. 1| Safety of adolescents~Regarding adolescents and young adults: ,
33 II, 7. 4. 1| European situation analysis regarding injuries and risk taking,
34 II, 7. 5 | recommends specific actions regarding surveillance, national action
35 II, 7. 5 | 2007).~ ~Also policy tools regarding “national action plans”
36 II, 8. 1. 2| disability, work limitations (regarding the kind of work or the
37 II, 8. 1. 2| relates to restrictions regarding activities in general. EU-SILC
38 II, 8. 1. 4| Public Health statistics) regarding the full implementation
39 II, 8. 1. 5| October 2003 a Communication regarding the policy follow up to
40 II, 8. 2. 1| and stereotypical beliefs regarding people with intellectual
41 II, 9 | determine numbers. Trends regarding alcohol drinking among young
42 II, 9 | alcohol itself, expectancies regarding its effects, and social
43 II, 9 | effects, and social norms regarding drunken comportment. Societies
44 II, 9. 1. 1| health.~ ~Further information regarding reproduction issues is presented
45 II, 9. 1. 2| terms of preventive action regarding environmental risk factors,
46 II, 9. 1. 2| disease) and e) practices regarding registration of a baby as
47 II, 9. 1. 2| different laws and practices regarding the recording of late terminations.
48 II, 9. 1. 2| differences in policy and practice regarding prenatal screening and TOPFA,
49 II, 9. 1. 2| prevalence estimate unless data regarding surgery in the first three
50 II, 9. 1. 2| determine numbers. Trends regarding alcohol drinking among young
51 II, 9. 1. 2| of the European directive regarding patient consent. Although
52 II, 9. 2. 2| Countries was data-rich regarding that child health inequalities
53 II, 9. 2. 4| alcohol itself, expectancies regarding its effects, and social
54 II, 9. 2. 4| effects, and social norms regarding drunken comportment. Societies
55 II, 9. 3. 1| the stigmatising thought regarding ED originates (Shah 2002).
56 II, 9. 4. 5| quality of service delivery regarding both health and long-term
57 II, 9. 4. 5| fostering the emergency regarding innovative, ICT-based products,
58 II, 9. 5. 3| about alcohol, expectancies regarding the effects of alcohol and
59 II, 9. 5. 3| alcohol and social norms regarding drunken comportment. This
60 II, 9. 5. 5| research material notably regarding the impact of men and boys’
61 III, 10. 2. 1| understanding of the main trends regarding drug use and drug-related
62 III, 10. 2. 1| helping problem drug users or regarding the accessibility of treatments
63 III, 10. 2. 1| findings over the past decade regarding physical activity as an
64 III, 10. 2. 1| response to current concerns regarding physical activity levels.~ ~
65 III, 10. 2. 1| when they were comparable regarding data collection methodology
66 III, 10. 2. 1| piece of EU legislation regarding the labelling of foodstuffs.
67 III, 10. 2. 4| trends” can be observed regarding the understanding of diseases,
68 III, 10. 3. 1| conducted over recent years regarding possible health effects
69 III, 10. 3. 2| conclusions can be drawn regarding their effects on humans.~ ~
70 III, 10. 3. 2| most sensitive parameter regarding human toxicity is the adverse
71 III, 10. 4. 1| setting the level of ambition regarding air quality in the EU up
72 III, 10. 4. 2| most sensitive parameter regarding human toxicity is the adverse
73 III, 10. 4. 2| the EEC Treaty in matters regarding food) establishes that,
74 III, 10. 4. 2| relate to the uncertainties regarding the interpretation of the
75 III, 10. 4. 2| associated complications regarding the tasks EFSA has relating
76 III, 10. 4. 2| opinions, on generic issues regarding pesticide risk assessment
77 III, 10. 4. 2| been defined and may vary regarding compound and type of exposure (
78 III, 10. 4. 2| mandate is risk communication regarding risks associated with the
79 III, 10. 5. 3| and safety requirements regarding the exposure of workers
80 IV, 11. 1. 5| are some important lessons regarding financial incentives that
81 IV, 11. 1. 5| general, and specifically regarding preventive health and lifestyles.
82 IV, 11. 3. 2| payer, and policy decisions regarding cost-sharing arrangements.
83 IV, 11. 5. 6| European common standards regarding legal, ethical, protection
84 IV, 11. 6. 4| pharmaceuticals. Decisions regarding benefit catalogues can only
85 IV, 11. 6. 4| the one hand, information regarding the cost-effectiveness of
86 IV, 11. 6. 4| websites and materials regarding validated indicators, nine
87 IV, 12. 5 | to Community initiatives regarding registries on cancer, based,
88 IV, 12. 10 | young people aged 15 to 19 regarding Clamydia. Website: www k
89 IV, 12. 10 | protection of the population regarding environmental health hazards
90 IV, 12. 10 | comply to high standards regarding biological and chemical
91 IV, 12. 10 | of drug use~particularly regarding polydrug usage~(including
92 IV, 12. 10 | waste disposal~ High~o 01 regarding "Packaging and Alternative
93 IV, 12. 10 | high~Law on Restrictions regarding Sale, Advertising and Use
94 IV, 12. 10 | initiatives has been undertaking regarding healthy nutrition, tobacco
95 IV, 12. 10 | Decisions 346-352/03/2007 regarding the list of localities within
96 IV, 12. 10 | water~ High~Law 458/2002 regarding drinking water modified
97 IV, 12. 10 | disposal~ High~GD 195/2005 regarding the environment protection~
98 IV, 12. 10 | Noise: public health law regarding occupational health~Human
99 IV, 12. 10 | communicate with the Riksdag regarding public health issues.~ ~
100 IV, 12. 10 | last 5 years regulations regarding environment have been harmonised
|
|
| |
